Gossamer Bio, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Gossamer Bio, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2025.
  • Gossamer Bio, Inc. Operating Lease, Payments for the quarter ending June 30, 2025 was $400K, a 63.6% decline year-over-year.
  • Gossamer Bio, Inc. Operating Lease, Payments for the twelve months ending June 30, 2025 was $3M, a 11.8% decline year-over-year.
  • Gossamer Bio, Inc. annual Operating Lease, Payments for 2024 was $3.8M, a 15.2% increase from 2023.
  • Gossamer Bio, Inc. annual Operating Lease, Payments for 2023 was $3.3M, a 3.13% increase from 2022.
  • Gossamer Bio, Inc. annual Operating Lease, Payments for 2022 was $3.2M, a 20% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $3M $400K -$700K -63.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $3.7M $800K -$100K -11.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $3.8M $1.1M +$300K +37.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $3.5M $700K +$100K +16.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.4M $1.1M +$300K +37.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 $3.1M $900K -$200K -18.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $3.3M $800K -$300K -27.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 $3.6M $600K +$100K +20% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $3.5M $800K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $3.5M $1.1M +$300K +37.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $3.2M $1.1M +$300K +37.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $2.9M $500K -$500K -50% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.4M $800K -$300K -27.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.7M $800K -$300K -27.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $4M $800K -$200K -20% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $4.2M $1M $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $4.2M $1.1M +$300K +37.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $3.9M $1.1M +$300K +37.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.6M $1M +$600K +150% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $3M $1M +$300K +42.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.7M $800K +$100K +14.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.6M $800K -$400K -33.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $3M $400K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $700K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $700K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.2M Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.